SCHEMBL2179845

SCHEMBL2179845

CC(=O)N1CCCC1C(=O)Nc1ccc(-c2nnc(-c3ccc(NC(=O)C4CCCN4C(=O)Cc4cccnc4)cc3)o2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HCRTR1 O43613 2/20 0.42
HCRTR2 O43614 2/20 0.42
HRH3 Q9Y5N1 1/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
HSD17B10 Q99714 2/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
FKBP1A P62942 1/20 0.41
KCNH2 Q12809 1/20 0.40
MAPK10 P53779 1/20 0.40
ACE P12821 1/20 0.40
CFD P00746 1/20 0.40
TRPV1 Q8NER1 1/20 0.40
RXFP3 Q9NSD7 2/20 0.40
ITGB1 P05556 2/20 0.40
ITGA4 P13612 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12488545 1.00 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AHCRTR1HCRTR2
SCHEMBL2197337 0.96 HCRTR1 (0.45) ALDH1A1MEN1KMT2AHCRTR1HCRTR2
SCHEMBL20054585 0.94 MEN1 (0.46) ALDH1A1MEN1KMT2AHCRTR1HCRTR2
SCHEMBL20054584 0.91 MEN1 (0.45) ALDH1A1MEN1KMT2AHCRTR1HCRTR2
SCHEMBL12489099 0.90 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AHCRTR1HCRTR2
SCHEMBL2175697 0.90 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AHCRTR1HCRTR2
SCHEMBL845401 0.86 ALDH1A1 (0.45) ALDH1A1MEN1KMT2AHCRTR1HCRTR2
SCHEMBL2195941 0.86 HSD17B10 (0.53) ALDH1A1MEN1KMT2AHCRTR1HCRTR2
SCHEMBL2193840 0.86 HSD17B10 (0.53) ALDH1A1MEN1KMT2AHCRTR1HCRTR2
SCHEMBL27896406 0.85 PORCN (0.39) ALDH1A1MEN1KMT2AHCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011082077-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-07-07 WO claimed